Despite large methylation ranges in the patient samples, both genes proved significantly hypermethylated in both MDS and AML compared to granulocytes (6.3% and 6.7%) and CD34+ cells (25.6% and 7.7%) from healthy donors; hypermethylation was more pronounced in the latter (Figure 3). This evidence concerns the gene CD34 and myelodysplastic syndrome.